Treatment of severe hypertriglyceridemia with continuous insulin infusion. 2011

Yesica Rodríguez Santana, and Andrea Nimo Román, and Iker García Sáez, and José Manuel López Alvarez, and Eduardo Consuegra Llapur, and Rafael González Jorge
Pediatric Intensive Care Unit, Hospital Universitario Materno-Infantil, 35016 Las Palmas de Gran Canaria, Spain.

Severe hypertriglyceridemia (SH) represents a therapeutic emergency because of the possibility of developing cardiovascular events and hyperlipemic acute pancreatitis (PA). Most patients with SH suffer primary or genetic abnormality in lipid metabolism in combination with a precipitating factor such as uncontrolled diabetes mellitus, alcoholism, and drug intake. The standard treatment of hypertriglyceridemia (HTG) with omega 3 fatty acids and fibrates, along with dietary changes, has no effect on an emergency situation. There are no clinical guidelines to SH, but therapy with insulin, heparin, a combination of both, plasmapheresis, or octreotide have been tested succesfully. We report the case of a 10-year-old girl with clinical acute pancreatitis and diabetic ketoacidosis debut, along with incidental finding of an SH, who had a good outcome after treatment with insulin intravenous infusion.

UI MeSH Term Description Entries

Related Publications

Yesica Rodríguez Santana, and Andrea Nimo Román, and Iker García Sáez, and José Manuel López Alvarez, and Eduardo Consuegra Llapur, and Rafael González Jorge
February 2022, Clinical endocrinology,
Yesica Rodríguez Santana, and Andrea Nimo Román, and Iker García Sáez, and José Manuel López Alvarez, and Eduardo Consuegra Llapur, and Rafael González Jorge
January 2021, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques,
Yesica Rodríguez Santana, and Andrea Nimo Román, and Iker García Sáez, and José Manuel López Alvarez, and Eduardo Consuegra Llapur, and Rafael González Jorge
January 2021, PloS one,
Yesica Rodríguez Santana, and Andrea Nimo Román, and Iker García Sáez, and José Manuel López Alvarez, and Eduardo Consuegra Llapur, and Rafael González Jorge
August 2015, The Medical journal of Malaysia,
Yesica Rodríguez Santana, and Andrea Nimo Román, and Iker García Sáez, and José Manuel López Alvarez, and Eduardo Consuegra Llapur, and Rafael González Jorge
February 1981, The Journal of the American Osteopathic Association,
Yesica Rodríguez Santana, and Andrea Nimo Román, and Iker García Sáez, and José Manuel López Alvarez, and Eduardo Consuegra Llapur, and Rafael González Jorge
August 2012, Diabetes research and clinical practice,
Yesica Rodríguez Santana, and Andrea Nimo Román, and Iker García Sáez, and José Manuel López Alvarez, and Eduardo Consuegra Llapur, and Rafael González Jorge
January 2019, Chemotherapy,
Yesica Rodríguez Santana, and Andrea Nimo Román, and Iker García Sáez, and José Manuel López Alvarez, and Eduardo Consuegra Llapur, and Rafael González Jorge
July 2020, Cureus,
Yesica Rodríguez Santana, and Andrea Nimo Román, and Iker García Sáez, and José Manuel López Alvarez, and Eduardo Consuegra Llapur, and Rafael González Jorge
May 2005, The American journal of emergency medicine,
Yesica Rodríguez Santana, and Andrea Nimo Román, and Iker García Sáez, and José Manuel López Alvarez, and Eduardo Consuegra Llapur, and Rafael González Jorge
March 2011, Journal of pediatric hematology/oncology,
Copied contents to your clipboard!